… However, the potential for even greater dose reduction when using MBIR was observed …
as a lung screening phantom (80% dose reduction potential). The difference in dose reduction …

… analyzed dose delays, dose reductions, RDI, and the association between chemotherapy
intensity and OS in patients with advanced/metastatic lung, breast, or ovarian cancer treated in …

… from lung cancer per 100,000 person-years in the low-dose … a relative reduction in mortality
from lung cancer with low-dose CT … was reduced in the low-dose CT group, as compared with …

… a reduction in lungcancer mortality with screening, probably due to insufficient sensitivity
of these tests for early lung cancer… for small lung cancers. Feasibility studies using low-radiation-…

… In the National Lung Screening Trial (NLST), screening with low-dose computed tomography
(CT) resulted in a 20% reduction in lung-cancer mortality among participants between the …

… Our results show a significant relative reduction of lung cancer–specific mortality of 17%
in the screening group compared with the control group, but no significant difference in the …

… cell lung cancer (NSCLC), but some patients experience toxicities and require dose reduction.
The purpose of this study was to evaluate the effect of gefitinib dose reduction on survival. …

… the doses delivered to the lungs and other normal tissues, when compared with conventional
field arrangements, 18,19 with standard dose-volume histogram reduction … to achieve dose …

… The present standard radiotherapy dose of 60 Gy used in non–small-cell lung cancer (NSCLC)
was established in a randomized trial, Radiation Therapy Oncology Group (RTOG) 7301, …

… at an earlier stage that were more often resectable, and better survival in the screened
groups; however, there was no reduction in the number of lung cancer deaths, and the Mayo trial …